
Methyltar-PG 750mcg/75mg Capsule
Marketer
Nectar Biopharma Pvt Limited
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Methyltar-PG 750mcg/75mg Capsule
Gabapentinoid-based analgesic, Methyltar-PG 750mcg/75mg Capsule, is a prescription medication for neuropathic pain management. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain perception. Additionally, it offers neuroprotective benefits, aiding in nerve fiber preservation and the repair of damaged nerve cells. Administered orally, Methyltar-PG 750mcg/75mg Capsules may be taken with or without food, ideally at bedtime for consistent plasma levels. Adherence to the prescribed dosage and duration is crucial, given its potential for habit formation. Missed doses should be taken promptly upon recall. Complete the entire course of therapy, regardless of symptom improvement. Abrupt cessation requires prior consultation with your physician. Commonly reported side effects include upper respiratory tract infection, increased appetite, elevated mood, tremors, visual blurring, dry mouth, vertigo, and somnolence. Avoid activities demanding concentration until the drug's effects are known. These side effects typically resolve spontaneously. Weight gain is a potential consequence; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all other medications is essential, as interactions may compromise efficacy or alter the drug's action. Disclose current or planned pregnancy and breastfeeding status to your doctor.
Uses of Methyltar-PG 750mcg/75mg Capsule
Managing neuropathic pain
Major Benefits of Methyltar-PG 750mcg/75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Methyltar-PG 750mcg/75mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.
Common Side effects of Methyltar-PG 750mcg/75mg Capsule:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Methyltar-PG 750mcg/75mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for Methyltar-PG 750mcg/75mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
How Methyltar-PG 750mcg/75mg Capsule works:
Each Methyltar-PG 750mcg/75mg capsule unites Methylcobalamin and Pregabalin. Methylcobalamin, a vitamin B variant, supports myelin production—the protective sheath around nerve fibers—and aids in nerve cell repair. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by influencing nerve cell calcium channel function. This dual action provides relief from neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Methyltar-PG 750mcg/75mg capsules and alcohol can result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Methyltar-PG 750mcg/75mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Methyltar-PG 750mcg/75mg Capsules while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Methyltar-PG 750mcg/75mg capsule could reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Methyltar-PG 750mcg/75mg Capsules cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Methyltar-PG 750mcg/75mg Capsules in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Methyltar-PG 750mcg/75mg Capsule :
Should you forget a Methyltar-PG 750mcg/75mg Capsule dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Methyltar-PG 750mcg/75mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
